黑料吃瓜群网

QUT PhD candidate Clarence Baxter has developed a browser-based smartphone app to deliver therapy for people recovering from surgery and those with lung conditions involving overproduction of mucus.

The QUT Inspire ISy app has been tested and compared with a Triflo II clinical incentive spirometry device by 24 healthy participants with the study鈥檚 results published in the BMJ Open Respiratory Research journal.

It is a web app using the built-in microphone available in all smartphones to detect inspiratory sounds, which offers a responsive animated graphic display for as long as detectable breath sound is sustained.

Clarence Baxter said the app, a 鈥榲irtual鈥� form of a longstanding clinical incentive spirometer (ISy) used to detect a person鈥檚 inspiratory breath, is intended to encourage persistence with repeated gradual maximal inspirations for respiratory therapy.

鈥淭he app was developed as a low-cost, easy-to-use way to promote repeated deep inhalations by patients to dislodge mucus from the airways so that it can be expelled by coughing,鈥� Baxter said.

鈥淩emoving mucus from the lungs is important when recovering after surgery as it may collect in the tiny air sacs or alveoli of the lungs while a patient is prone for a long time, presenting risks of developing respiratory infections or pneumonia.

鈥淭he traditional clinical ISy device has a tube from which users inhale in order to create a vacuum to raise three spheres in separate clear chambers. The aim is to keep the three spheres aloft using a sustained slow deep inhalation to encourage dislodgement of mucus from the airways.

鈥淥bviously the user can see how they are doing by watching the spheres rise in the clinical ISy device, and so we used this visualisation virtually in the app to give users the same visual cues regarding their inhalations.鈥�

In the first phase of this new clinical study, participants compared three gradual maximal inhalations using the QUT ISy app with three inhalations using the clinical ISy device.

鈥淲e randomly assigned the testing order so that some participants used the app first and the ISy second and vice versa to avoid any device testing order effects.

鈥淯sability was measured for three factors: effectiveness 鈥� the duration of sustained inhalation effort; efficiency 鈥� assessed by using the distance participants held their phones from their mouths; and, user satisfaction assessed by a post-test questionnaire and qualitatively through semi-structured interviews.

鈥淣o significant difference was found between the duration of inhalations (in seconds) using the QUT ISy app compared with the Triflo II clinical ISy device.

While participants were asked to hold the phone less than 5 cm from their mouths to capture the inhalation sound, most held their phones on average about 13 cm away, possibly to better view the screen, Baxter said.

鈥淓ven so, this distance was within the detection range of approximately 50 cm for medium and high inhalation flow sounds identified in an earlier simulation study using this app,鈥� he said.

鈥淯ser satisfaction was high with most participants preferring the new virtual app as best for displaying inspirations. They reported the app鈥檚 screen display had the advantage of responsiveness and compactness over the Triflo II.鈥�

People with cystic fibrosis have an ongoing overproduction of mucus (including mucus in the airways) and could benefit from using the app as they would need no other equipment other than their smartphone, according to Baxter.

鈥淥ther potential users include people with chronic obstructive pulmonary disease who may have reduced lung elasticity or other pathological lung changes resulting in accumulation of mucus.

鈥淎s this study shows healthy participants reported the app encouraged inhalations of comparable vigour and duration with the traditional IS device, further studies with more vulnerable groups with these relevant disease conditions are warranted.鈥�